andrew huberman on glp 1 “Everyone Should be a GLP-1 Medication”, “Should everyone just be on a GLP-1?” Wrong question. The real question is: How do we USE GLP-1s effectively? Because this isn’t GLP-1 vs. lifestyle change… Weight Loss Medications | Ask

Relationship with Clinical Phenotype and Metabolic Comorbidities Metabolic comorbidities may influence the clinical presentation of PD, leading to an earlier onset of cognitive impairment, a greater burden of axial symptoms, and a reduced response to dopaminergic medication [62]

Most research involves oral supplementation, not kind patches

That last one surprises people

Community protocols describe no loading phase dosing begins at the full 500 mcg on day one

So why, then, would anyone feel the need to introduce more

Most patients describe it less as appetite suppression and more as food taking up less mental space